The agency's findings suggest that Philips Respironics has known about the potential foam degradation issues for years.
These medical device startups are hoping to transform healthcare, and they've had a pretty good year. What do you think?
Globus Medical could be looking into acquiring Nuvasive, according to a Reuters report.
HHS just withdrew a Trump Administration-established policy limiting FDA’s ability to regulate laboratory-developed tests.
The London-based company said the center would be based in Munich, Germany.
Although cardiac perforations are rare, FDA says the risk of major complications following cardiac perforation may be higher in patients who receive a Medtronic Micra leadless pacing system.
Cardialen has won a nod from FDA for an IDE to begin a clinical trial of its Multipulse therapy.